Project Details
Description
A Phase I/IIa, First-in-Human, Multicenter, Monotherapy and Combination-Therapy with Nivolumab, Dose-Finding and Dose-Expansion Study of [212Pb]VMT01 Melanocortin-1-Receptor-Targeted...
| Status | Active |
|---|---|
| Effective start/end date | 6/24/25 → 6/23/36 |
Funding
- PERSPECTIVE THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.